NCT06611046View on ClinicalTrials.gov

MicroRNA Profile As a Biomarker of Liver Damage in Different Types of Liver Donors.

CompletedOBSERVATIONAL
Enrollment

28

Participants

Timeline

Start Date

October 2, 2019

Primary Completion Date

July 27, 2021

Study Completion Date

September 1, 2024

Conditions
MicroRNA ProfileLiver TransplantOrgan Donor
Interventions
OTHER

organ donor

"Observational study with sample collection of serum, liver tissue and perfusate fluid from liver donors. No specific interventions were done to the donors as part of the study. The samples were analyzed for specific microNA expression by RT-qPCR.~\*Control group: only serum samples were collected from this group."

Trial Locations (1)

08035

Vall d Hebron University Hospital, Barcelona

All Listed Sponsors
collaborator

Vall Hebron Insitut Recerca

NETWORK

lead

Mar Dalmau

OTHER

NCT06611046 - MicroRNA Profile As a Biomarker of Liver Damage in Different Types of Liver Donors. | Biotech Hunter | Biotech Hunter